Serum TNC levels were greater in pancreatic cancer patients than in controls, and TNC levels correlated with the inflammatory markers neutrophil-to-lymphocyte ratio (NLR) and albumin and the tumor marker carbohydrate antigen 19–9 (CA19-9). Here, ALB is linked to neoplasm.